237.1 ð é«åžçç
237.1.0.1 ð äžé éé»
237.1.0.1.1 Adult Intestinal Tapeworms
| Species | Source | Clinical | Treatment |
|---|---|---|---|
| Taenia saginata | Undercooked beef | Often asymptomatic; mild GI; proglottids in stool | Praziquantel single dose or niclosamide |
| Taenia solium | Undercooked pork | Similar to above + cysticercosis if eggs ingested | Praziquantel + niclosamide |
| Diphyllobothrium latum | Undercooked freshwater fish (pike, salmon â N hemisphere, Mediterranean) | Often asymptomatic; B12 deficiency + megaloblastic anemia | Praziquantel |
| Hymenolepis nana | Person-to-person fecal-oral (small humans + insects) | Mostly asymptomatic; abdominal pain | Praziquantel |
| Hymenolepis diminuta | Insect-contaminated grain | Mild | Praziquantel |
237.1.0.1.2 Cysticercosis (Taenia solium Larva)
- #1 parasitic CNS disease worldwide
- From ingestion of T. solium eggs (not from pork tapeworm carrier himself, but from contaminated food/water or self-infection)
- Latin America, sub-Saharan Africa, S Asia endemic
- Eggs hatch in human â oncospheres invade tissue + form cysticerci
- Tissue cysts in muscle, brain, eye, subcutaneous
237.1.0.1.2.1 Neurocysticercosis (NCC)
- Most clinically relevant
- Etiology of acquired epilepsy worldwide (especially endemic regions)
- 4 forms:
- Active: viable cysts + immune attack â seizures, hydrocephalus, mass effect
- Transitional: degenerating cysts
- Calcified: inactive (residual)
- Extraparenchymal: cisternal, ventricular, intramedullary
237.1.0.1.3 Clinical (Neurocysticercosis)
- Seizures (most common presentation; new-onset adult)
- Hydrocephalus (cysts blocking CSF flow)
- Headache + focal neuro
- Increased intracranial pressure
- Cognitive / behavioral changes
237.1.0.1.4 Diagnosis
- MRI brain (most sensitive): viable cysts (T1 hypointense, T2 hyperintense; scolex visible âhole-with-dotâ sign); transitional (ring-enhancing); calcified (CT shows calcification)
- CT brain: detects calcifications well
- Serology (anti-cysticercus antibody â EITB Western blot most specific)
- CSF antibody (less reliable)
237.1.0.1.5 Treatment Neurocysticercosis
- Antiparasitic:
- Albendazole 15 mg/kg/d PO Ã 8-30 days OR
- Albendazole + praziquantel combination (large burden)
- Steroid (dexamethasone) for inflammatory response to dying cysts
- Anticonvulsants for seizures (chronic, may continue years)
- Surgical: shunt for hydrocephalus, resection for symptomatic single cyst, endoscopic for ventricular cysts
- Endemic public health: deworming + sanitation + pork inspection
237.1.0.1.6 Echinococcosis (Hydatid Disease)
- Larval cyst infection from dog tapeworm
- 2 main species:
- Echinococcus granulosus â Cystic echinococcosis (CE) â solitary cyst, sheep/dog cycle
- Echinococcus multilocularis â Alveolar echinococcosis (AE) â infiltrative tumor-like, fox/dog cycle, Arctic + Europe
- Other: E. vogeli, E. oligarthrus (S America, rare)
237.1.0.1.6.1 Cystic Echinococcosis (CE)
- Dog definitive host, sheep + livestock intermediate
- Human accidental intermediate host
- Worldwide: Mediterranean, Mid East, S America, E Africa, China, Central Asia
- Liver (#1, 70%) + lung + brain + bone + spleen + muscle
- Slow-growing fluid-filled cyst
- Multiple daughter cysts within mother cyst (hydatid sand)
- Asymptomatic many years
- Sx from mass effect or rupture
- Rupture â anaphylaxis + dissemination of daughter cysts
237.1.0.1.7 Diagnosis Echinococcosis
- Imaging (US, CT, MRI): liver cyst â characteristic appearance
- Serology (CE-specific; AE-specific)
- WHO classification of cysts: CE1-CE5 active to inactive
- AE: PET-CT for staging
237.1.0.1.8 Treatment Echinococcosis
237.1.0.1.8.1 Cystic Echinococcosis (CE)
- Albendazole 15 mg/kg/d à 3-6 months (or longer)
- PAIR (Puncture-Aspiration-Injection-Reaspiration) â percutaneous treatment for select cysts
- Surgical â cyst removal (be careful not to rupture intraoperatively)
- Observation for inactive CE4/CE5 cysts
- WHO management based on cyst stage
237.1.0.2 1ïžâ£ Adult Intestinal Tapeworms
237.1.0.2.1 Taenia saginata (Beef Tapeworm)
237.1.0.2.1.1 Life Cycle
- Adult worm in human small intestine (up to 25 m long; live for years)
- Proglottids (segments) released in stool
- Cattle ingest eggs â larvae in muscle
- Human ingests undercooked beef with cysticerci â matures to adult in intestine
237.1.0.2.1.2 Clinical
- Often asymptomatic
- Mild GI: abdominal pain, anorexia, mild diarrhea, weight loss
- Active motile proglottids in stool / underwear (distinctive complaint)
- Rare: appendicitis-like, intestinal obstruction
237.1.0.2.2 Taenia solium (Pork Tapeworm)
237.1.0.2.2.1 Life Cycle
- Adult in human intestine (similar to T. saginata)
- Pigs are normal intermediate host (cysticerci in muscle)
- Human can be both definitive (adult worm from undercooked pork) AND intermediate (eggs â cysticercosis)
- Major importance: fecal contamination + autoinfection can cause cysticercosis in tapeworm carrier or contacts
237.1.0.2.3 Diphyllobothrium latum (Fish Tapeworm)
237.1.0.2.3.1 Source
- Undercooked freshwater fish (pike, salmon, perch)
- Endemic: N hemisphere (Scandinavia, Russia, Baltic, Great Lakes USA, Japan, Mediterranean)
- âSushi tapewormâ (less commonly from marine fish; mostly freshwater)
237.1.0.2.4 Hymenolepis nana (Dwarf Tapeworm)
237.1.0.2.4.1 Life Cycle
- Most common cestode infection worldwide
- Person-to-person fecal-oral (egg viable in fresh stool)
- Insects (beetles) can serve as intermediate
- Internal autoinfection possible (heavy burden in immunocompromise)
- Pediatric + crowded settings
237.1.0.3 2ïžâ£ Cysticercosis + Neurocysticercosis
237.1.0.3.1 Background
- Larval form of Taenia solium
- Egg ingestion (not pork) causes cysticercosis
- Autoinfection in tapeworm carriers (oro-fecal)
- Contamination from another carrier (food handler, household)
- Latin America, sub-Saharan Africa, S Asia, parts of E Europe endemic
- Major cause of acquired epilepsy in endemic + immigration-affected developed countries
237.1.0.3.2 Life Cycle of Eggs in Human
- Eggs ingested (food, water, fingers contaminated by fecal eggs)
- Hatch in intestine â oncospheres
- Penetrate intestinal wall â bloodstream â tissue
- Tissue cysts (cysticerci) form in:
- Brain (neurocysticercosis)
- Subcutaneous tissue
- Muscle
- Eye
- Heart (rare)
- Cysticerci viable for years â eventually die â degenerate â calcify
237.1.0.3.3 Neurocysticercosis (NCC)
237.1.0.3.3.2 Parenchymal NCC
- Active: viable cysts (T1 hypointense, T2 hyperintense, with scolex; no enhancement)
- Transitional: degenerating cysts (ring-enhancing, edema)
- Calcified: dead cysts (calcification on CT)
237.1.0.3.3.3 Extraparenchymal NCC
- Cisternal (basal cisterns) â racemose form (grape-like, often inflammatory)
- Ventricular â risk of acute hydrocephalus
- Intramedullary spinal cord â rare
237.1.0.3.3.4 Clinical
- New-onset seizures (#1; cortex active or calcified)
- Hydrocephalus + intracranial hypertension (ventricular, subarachnoid, racemose)
- Headache + focal neurological signs
- Cognitive / behavioral changes
- Ocular (rare): vision loss, decreased vision
237.1.0.3.3.6 Imaging (Critical)
- MRI > CT for soft tissue + cysts + scolex
- CT detects calcifications well (chronic disease)
- Active: T1 hypo / T2 hyper / no enhancement (viable)
- Transitional: ring-enhancing with edema (inflammatory)
- Calcified: cluster on CT (inactive)
- Number of cysts, location, viability inform Tx
237.1.0.3.3.7 Serology
- EITB (Enzyme-linked Immunoelectrotransfer Blot) â most specific Ab test
- 90%+ sensitivity in multi-cyst disease, lower in single-cyst
- May be negative in calcified-only disease
237.1.0.3.3.9 Differential
- Tuberculoma (granulomatous mass â biopsy / response to TB Tx)
- Pyogenic / fungal abscess
- Primary CNS lymphoma
- Glioma
- Metastases
- Toxo (in HIV)
237.1.0.3.3.11 Antiparasitic
- Albendazole 15 mg/kg/d PO Ã 10-15 days for most parenchymal disease
- Albendazole + praziquantel combination for high cyst burden / extraparenchymal
- Albendazole alone for single-lesion / limited
- Avoid antiparasitic in calcified-only disease (no benefit)
237.1.0.3.3.12 Steroid (Dexamethasone)
- Critical adjunct
- Reduces inflammatory response to dying parasites
- 6-24 mg/d PO Ã 2-3 weeks
- Higher dose for severe / extraparenchymal
- Start before / concurrent with albendazole
237.1.0.3.3.13 Anticonvulsants
- Long-term (often years, sometimes lifelong)
- For seizures
- Levetiracetam, valproate, carbamazepine common
- Continue until calcification stable + no seizures à 1-2 yr
237.1.0.3.3.14 Surgical
- Ventricular shunt for hydrocephalus
- Endoscopic removal of intraventricular cysts
- Resection of symptomatic single cyst (rare)
- Decompression for severe mass effect
237.1.0.3.3.15 Treatment by Form
| Form | Approach |
|---|---|
| Single calcified | Anticonvulsants only; no antiparasitic |
| Single viable parenchymal | Albendazole 15 mg/kg/d à 10-15d + dex |
| Multiple parenchymal | Albendazole + praziquantel + dex |
| Subarachnoid / racemose | Albendazole + praziquantel + high-dose dex + shunt; long course |
| Ventricular | Endoscopic removal + shunt + albendazole + dex |
| Spinal | Albendazole + dex; surgery for compression |
237.1.0.4 3ïžâ£ Echinococcosis
237.1.0.4.1 Species
- E. granulosus â Cystic Echinococcosis (CE)
- E. multilocularis â Alveolar Echinococcosis (AE)
- E. vogeli, E. oligarthrus â Neotropical (S America rare)
237.1.0.4.2 Cystic Echinococcosis (CE)
237.1.0.4.2.1 Life Cycle
- Dog definitive host (adult worms in dog intestine)
- Sheep + cattle + livestock intermediate (cysts in liver, lung)
- Human accidental intermediate (ingestion of eggs from dog feces or contaminated produce)
- Worldwide: Mediterranean, Mid East, S America, sub-Saharan Africa, China, Central Asia
237.1.0.4.2.2 Pathology
- Liver (#1, 70%) + lung (20%) + brain + bone + spleen + muscle
- Slow-growing fluid-filled cyst (cm-decades to grow)
- Inner germinative layer + outer laminated layer + outer adventitia (host)
- Daughter cysts within mother cyst
- Hydatid sand = protoscoleces in cyst fluid
237.1.0.4.2.3 Clinical
- Often asymptomatic for years
- Mass effect: hepatomegaly, biliary obstruction, cough (lung cyst), seizures (brain)
- Rupture: anaphylaxis + dissemination of daughter cysts â secondary echinococcosis
- Bacterial superinfection
- Calcification (inactive cysts)
237.1.0.4.2.4 Diagnosis
- Imaging (US, CT, MRI):
- Anechoic cyst with daughter cysts (pathognomonic âhoneycombâ or âball-of-yarnâ)
- WHO classification CE1-CE5 (active CE1-CE2; transitional CE3; inactive CE4-CE5)
- Calcification on CT (chronic/inactive)
- Serology (echinococcal IgG): 90%+ sensitivity in CE; cross-reacts with other parasites
- Aspiration can cause rupture + dissemination â only do for therapy (PAIR) with specific protocol
237.1.0.4.2.6 WHO Cyst Stage Classification
| Stage | Activity | Treatment |
|---|---|---|
| CE1 (active, unilocular) | Active | Albendazole; PAIR if accessible |
| CE2 (active, multivesicular) | Active | Albendazole; surgery if accessible |
| CE3a (transitional, water-lily sign) | Transitional | Albendazole; PAIR |
| CE3b (mostly solid) | Transitional | Albendazole |
| CE4 (inactive, mostly solid) | Inactive | Observation |
| CE5 (calcified, inactive) | Inactive | Observation |
237.1.0.4.2.8 Albendazole
- 15 mg/kg/d PO divided à 3-6 months (or longer for multi-cyst, recurrent)
- WHO essential medicine
- Side effects: hepatotoxicity, leukopenia, alopecia long course
- LFT monitoring
237.1.0.4.2.9 PAIR (Puncture-Aspiration-Injection-Reaspiration)
- For accessible cysts CE1, CE3a (some CE2)
- Liver mainly
- Albendazole pre + post-procedure (prevent dissemination)
- Aspirate cyst â inject scolicidal agent (95% ethanol, 20% saline) â reaspirate
- Avoid in bone, lung, brain
237.1.0.4.3 Alveolar Echinococcosis (AE)
237.1.0.4.3.1 Life Cycle
- Red fox (definitive host) + dog (definitive in some) + rodent intermediate
- Arctic + sub-Arctic + Central Europe + Western China + N N. America (Alaska)
- Human accidental intermediate (ingestion of eggs from fox feces or contaminated berries / wild produce)
237.1.0.4.3.2 Pathology
- Infiltrative growth (vs unilocular cyst in CE)
- Liver primary, but can metastasize like cancer
- Multilocular vesicles, tumor-like
- Lobar invasion â liver failure
- Vascular invasion + distant metastasis (lung, brain)
237.1.0.4.3.3 Clinical
- Mimics liver cancer / cholangiocarcinoma
- Asymptomatic until late
- Hepatomegaly, jaundice, weight loss
- Hilar mass effect
- Metastatic disease
- Fatal if untreated (5-yr survival < 30% historically; improved with treatment)